What is the Undescended Testicle Market Size and Growth Rate?
- As per Data Bridge Market Research analysis, the undescended testicle market was valued at USD 117.42 million in 2025 and is projected to reach USD 180.20 million by 2033, growing at a CAGR of 5.50% from 2026 to 2033.
- The market is experiencing consistent growth driven by increasing awareness and early diagnosis of cryptorchidism, rising demand for pediatric urological treatments, and advancements in minimally invasive surgical techniques, including laparoscopic orchiopexy.
- The association of undescended testicles with impaired fertility, testicular cancer, and other reproductive complications, combined with growing emphasis on early intervention, is encouraging parents, healthcare providers, and pediatric urologists to pursue timely diagnosis and treatment. Increasing adoption of laparoscopic procedures, improved surgical techniques, and established clinical guidelines recommending early surgical correction are supporting the expansion of treatment services across global healthcare markets.
Market Size & Forecast
- Global Market Value (2025): USD 117.42 Million
- Expected Market Value (2033): USD 180.20 Million
- Forecast CAGR (2026–2033): 5.50%
- Leading Region in 2025: North America
- Fastest Growing Region: Asia Pacific
What are the Major Takeaways of the Undescended Testicle Market?
- North America dominated the undescended testicle market with the largest revenue share of 37.2% in 2025, supported by advanced pediatric healthcare infrastructure, high awareness of cryptorchidism, and improved access to specialized diagnostic and surgical services.
- Asia-Pacific is expected to be the fastest-growing region at a CAGR of 8.2% from 2026 to 2033, fueled by rising healthcare expenditure, improving pediatric healthcare infrastructure, increasing awareness of cryptorchidism, and expanding access to early diagnosis and surgical treatment.
- The open surgery segment led the market with a 58% share in 2025, driven by its established clinical effectiveness and widespread use in treating palpable undescended testicles.
- Laparoscopy are the fastest-growing diagnosis type, projected to register a CAGR of 6.5%, reflecting the surge in adoption of minimally invasive procedures for non-palpable and intra-abdominal undescended testicles.
- The neonates segment dominated the population category with a 82.1% revenue share in 2025, led by increasing emphasis on newborn screening and early identification of congenital cryptorchidism
- Retractile testicle accounted for 61.9% of the market share in 2025, preferred by the need for regular pediatric examinations and differentiation from true undescended testicles.
- The testicular cancer segment is the fastest-growing complications category, with a CAGR of 7.1%, driven by growing awareness of the association between undescended testicles and future testicular malignancy.
Report Scope and Undescended Testicle Market Segmentation
|
Attributes |
Undescended Testicle Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
North America
Europe
Asia-Pacific
Middle East and Africa
South America
|
|
Key Market Players |
|
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. |
What is the Key Trend in the Undescended Testicle Market?
- Pediatric urology centers are increasingly adopting advanced laparoscopic techniques to diagnose and treat undescended testicles, particularly in children with non-palpable testes, while improving surgical precision and treatment outcomes.
- For instance, in January 2024, a study published in Shenzhen Children's Hospital, China, published a prospective comparative study in Pediatric Surgery International involving 223 children with undescended testicles. The study found that single-site laparoscopic orchiopexy achieved a 99.0% success rate, comparable to 99.2% with conventional laparoscopic surgery, highlighting growing adoption of minimally invasive surgical techniques.
- Laparoscopic orchiopexy enables surgeons to locate intra-abdominal testes, assess anatomical structures, and perform corrective procedures through minimally invasive techniques, reducing the need for extensive surgical exploration.
- Hospitals and specialized pediatric surgical centers are increasingly emphasizing early surgical intervention to preserve fertility potential and minimize long-term complications associated with untreated cryptorchidism.
- For instance, in November 2024, a study published a randomized clinical trial in International Urology and Nephrology comparing laparoscopic and open orchiopexy in 208 children with high-inguinal undescended testicles. The study reported that 100% of children undergoing laparoscopic orchiopexy achieved a lower testicular position at one-year follow-up, compared with 72.6% following open surgery, supporting the clinical adoption of minimally invasive procedures
- As pediatric healthcare providers continue prioritizing minimally invasive procedures and improved surgical outcomes, the adoption of laparoscopic orchiopexy is expected to accelerate, strengthening its role in the treatment of complex undescended testicle cases.
What are the Key Drivers of the Undescended Testicle Market?
- The increasing recognition of cryptorchidism as a common congenital condition has significantly increased demand for early diagnosis, pediatric urological consultations, and timely corrective surgical procedures to reduce fertility-related complications.
- For instance, in February 2024, a study published in the International Journal of Urology evaluating cryptorchidism diagnosis and factors associated with delayed orchiopexy. The study analyzed 731 patients and found that 90% were initially diagnosed during routine public health checkups, highlighting the importance of early screening and timely pediatric referrals.
- Healthcare providers are increasingly prioritizing early orchiopexy to preserve fertility potential, reduce the risk of testicular malignancy, and prevent progressive damage to germ cells associated with delayed treatment.
- For instance, in January 2024, a study published in Pediatric Surgery International examining the timing of diagnosis and surgical treatment of congenital cryptorchidism in Greece. The retrospective study included 217 children who underwent orchiopexy and assessed compliance with recommendations for surgical correction by 18 months of age, reinforcing demand for early diagnosis and specialized pediatric surgical care.
- With healthcare systems increasingly emphasizing early diagnosis, fertility preservation, and evidence-based pediatric treatment, demand for specialized undescended testicle management is expected to increase across global healthcare markets.
What Factors are Challenging the Growth of the Undescended Testicle Market?
- Undescended testicle treatment requires specialized pediatric surgical expertise, appropriate anesthesia facilities, and advanced laparoscopic equipment, increasing the overall cost of diagnosis and corrective procedures.
- For instance, in August 2023, a study published in Saudi Medical Journal examining awareness and barriers to timely treatment of undescended testicles in Saudi Arabia. Among 2,360 respondents, 54.92% had never heard of the condition, while 22.3% identified a lack of community awareness as a reason for delayed intervention. The findings highlight inadequate public awareness and gaps in early diagnosis as barriers to market growth.
- These requirements limit access to timely treatment among patients in developing economies, particularly in regions with limited pediatric urologists, inadequate healthcare infrastructure, and affordability constraints.
- The complexity of treating non-palpable and intra-abdominal testes also creates additional challenges, as specialized surgical procedures require experienced surgeons and careful postoperative monitoring to prevent complications such as testicular atrophy and re-ascent.
- For instance, in October 2024, a study published in Acta Paediatrica examining knowledge and clinical management of undescended testicles among 386 physicians working in Swedish child health centers. The study found that approximately two-thirds were unaware that surgery is recommended before one year of age, while one-fifth had never received guidance on examination techniques, highlighting gaps in clinical training and timely referral pathways.
- The high resource requirements, uneven availability of specialized pediatric surgical services, and potential postoperative complications continue to restrict treatment accessibility, particularly across underserved and price-sensitive healthcare markets.
How is the Undescended Testicle Market Segmented?
The undescended testicle market is segmented on the basis of diagnosis, population, indication, complications, end-user, and distribution channel.
- By Diagnosis
On the basis of diagnosis, the undescended testicle market is segmented into laparoscopy and open surgery. The open surgery segment is estimated to dominate the market with 58% share in 2025, owing to its established clinical effectiveness and widespread use in treating palpable undescended testicles. These procedures are commonly performed to mobilize the spermatic cord and position the testicle within the scrotum. Their established surgical protocols and availability across pediatric surgical departments further support adoption. Open orchiopexy is widely used for inguinal and low-positioned testicles. Strong clinical experience and established treatment guidelines continue to reinforce the segment's dominance.
The laparoscopy segment is projected to register the fastest growth at an estimated CAGR of 6.5% from 2026 to 2033, driven by increasing adoption of minimally invasive procedures for non-palpable and intra-abdominal undescended testicles. Diagnostic laparoscopy allows surgeons to identify the location and anatomical condition of testicles that cannot be detected through physical examination. The technique also enables corrective procedures during the same surgical session. Advancements in laparoscopic instruments, visualization systems, and pediatric surgical techniques are improving procedural precision. Increasing preference for minimally invasive approaches in complex pediatric cases is further supporting adoption. Growing availability of specialized pediatric surgical facilities is expected to accelerate segment growth.
- By Population
On the basis of population, the undescended testicle market is segmented into neonates and children. The neonates segment is estimated to dominate the market with 82.1% share in 2025, supported by increasing emphasis on newborn screening and early identification of congenital cryptorchidism. Physical examination during routine neonatal assessments enables healthcare professionals to identify the absence of one or both testicles from the scrotum. Premature newborns represent an important patient group because the incidence of undescended testicles is substantially higher among preterm infants. Growing awareness of congenital abnormalities is encouraging parents to seek early pediatric consultations. Improved newborn examination protocols and referral pathways are strengthening early diagnosis.
The children segment is projected to register the fastest growth at an estimated CAGR of 6.2% from 2026 to 2033, driven by increasing diagnosis of persistent and acquired undescended testicles during childhood. Children diagnosed with undescended testicles require regular monitoring to determine whether spontaneous descent occurs. Surgical intervention is generally recommended when the testicle remains undescended after infancy. The segment benefits from increasing awareness among parents regarding fertility-related complications and the importance of early treatment. Pediatric hospitals and urology centers play an important role in providing specialized diagnosis and orchiopexy procedures. Increasing emphasis on early surgical correction continues to support segment growth.
- By Indication
On the basis of indication, the undescended testicle market is segmented into retractile testicle and ascending testicle. The retractile testicle segment is estimated to dominate the market with 61.9% share in 2025, supported by the need for regular pediatric examinations and differentiation from true undescended testicles. Retractile testicles move temporarily into the upper scrotal or inguinal region because of an active cremasteric reflex. Unlike true undescended testicles, they can generally be moved into the scrotum and remain there temporarily. Increasing awareness among pediatricians and parents regarding secondary testicular ascent is supporting regular monitoring. Improved clinical assessment helps distinguish retractile testicles from persistent cryptorchidism.
The ascending testicle segment is projected to register the fastest growth at an estimated CAGR of 6.8% from 2026 to 2033, driven by increasing recognition of acquired cryptorchidism among children whose testicles were previously positioned normally in the scrotum. Ascending testicles may develop when a previously descended testicle moves upward and remains outside the scrotum. The condition requires careful clinical examination to distinguish it from retractile testicles. Increasing awareness among pediatricians regarding secondary testicular ascent is supporting early diagnosis. Children with persistent acquired undescended testicles may require corrective surgical intervention to reduce potential reproductive complications.
- By Complications
On the basis of complications, the undescended testicle market is segmented into infertility and testicular cancer. The infertility segment is estimated to dominate the market with 68% share in 2025, driven by the strong association between untreated or delayed treatment of cryptorchidism and impaired reproductive potential. Undescended testicles may experience abnormal temperature exposure, which can negatively affect germ cell development and sperm production. Bilateral cryptorchidism is particularly associated with reduced fertility and paternity outcomes. Increasing awareness of long-term reproductive complications is encouraging early diagnosis and corrective surgical intervention. Pediatric urologists increasingly emphasize timely orchiopexy to preserve testicular function.
The testicular cancer segment is projected to register the fastest growth at an estimated CAGR of 7.1% from 2026 to 2033, supported by growing awareness of the association between undescended testicles and future testicular malignancy. Cryptorchidism is recognized as an important risk factor for testicular cancer, particularly when surgical correction is delayed. Early orchiopexy helps position the testicle within the scrotum, allowing easier clinical examination and long-term monitoring. Healthcare professionals are increasingly emphasizing patient education regarding malignancy risks associated with untreated cryptorchidism. Improved diagnostic awareness and long-term follow-up are strengthening the importance of cancer risk management. Growing emphasis on preventive pediatric urological care is further supporting segment growth.
- By End-User
On the basis of end-user, the undescended testicle market is segmented into hospitals, specialty clinics, and others. The hospitals segment is estimated to dominate the market with 68% share in 2025, driven by the availability of specialized pediatric surgeons, advanced diagnostic facilities, and comprehensive surgical infrastructure. Hospitals provide integrated services, including newborn screening, pediatric consultations, diagnostic evaluation, anesthesia, and corrective orchiopexy. Complex cases involving non-palpable and intra-abdominal testicles generally require specialized surgical facilities available in tertiary care hospitals. The presence of multidisciplinary teams also supports the management of associated congenital abnormalities. Increasing investments in pediatric surgical departments and advanced laparoscopic equipment are strengthening hospital-based treatment capabilities.
The specialty clinics segment is projected to register the fastest growth at an estimated CAGR of 7.0% from 2026 to 2033, driven by increasing demand for specialized pediatric urology consultations and focused treatment services. These clinics provide targeted assessment and follow-up for children diagnosed with undescended testicles. Growing awareness of early diagnosis is encouraging parents to seek consultations from pediatric urology specialists. Specialty clinics also support long-term monitoring of retractile and ascending testicles. Increasing availability of minimally invasive surgical expertise and improved referral networks are strengthening their role in treatment delivery. Their focus on specialized consultations and personalized follow-up is expected to support segment growth.
- By Distribution Channel
On the basis of distribution channel, the undescended testicle market is segmented into hospital pharmacy, retail pharmacy, online pharmacies, and others. The hospital pharmacy segment is estimated to dominate the market with 52% share in 2025, supported by the extensive use of hospital-based treatment facilities for surgical management of undescended testicles. Patients undergoing orchiopexy generally receive prescribed medications, including anesthetic-related medicines, antibiotics when indicated, and postoperative pain management therapies through hospital pharmacies. The integration of pharmacy services with surgical departments ensures timely availability of prescribed medications. Hospital pharmacies also facilitate medication management during inpatient care and postoperative recovery. Increasing hospital-based pediatric surgical procedures are supporting demand through this channel.
The online pharmacies segment is projected to register the fastest growth at an estimated CAGR of 8.0% from 2026 to 2033, driven by increasing digital healthcare adoption and the growing preference for convenient access to prescribed postoperative medications. Online platforms enable caregivers to purchase prescribed medicines without repeated visits to physical pharmacies. Expanding internet penetration and digital prescription services are improving access to pharmaceutical products. Home delivery services are particularly beneficial for parents managing postoperative care and follow-up appointments for children. Increasing adoption of e-commerce healthcare platforms is further supporting channel development. Improved digital payment systems and growing consumer confidence in regulated online pharmacies are expected to accelerate segment growth.
Which Region Holds the Largest Share of the Undescended Testicle Market?
- North America dominated the undescended testicle market with the largest revenue share of 37.2% in 2025, supported by advanced pediatric healthcare infrastructure, high awareness of cryptorchidism, and improved access to specialized diagnostic and surgical services.
- The region also benefits from favorable healthcare reimbursement policies, increasing investments in pediatric surgical facilities, and widespread access to advanced diagnostic and minimally invasive treatment procedures. Growing emphasis on early diagnosis, fertility preservation, and timely orchiopexy, particularly in the U.S. and Canada, continues to strengthen North America's leadership position in the global market.
U.S. Undescended Testicle Market Insight
The U.S. undescended testicle market is witnessing strong growth due to increasing awareness of congenital urological conditions, rising demand for early pediatric diagnosis, and advancements in minimally invasive surgical procedures. The country's well-established healthcare infrastructure, along with the availability of specialized pediatric urologists and advanced diagnostic facilities, is driving demand for effective cryptorchidism treatment. In addition, growing emphasis on fertility preservation, early orchiopexy, and improved neonatal screening practices is accelerating treatment adoption across hospitals and specialized pediatric surgical centers.
Asia-Pacific Undescended Testicle Market Insight
The Asia-Pacific undescended testicle market is expected to witness rapid growth, driven by increasing awareness of congenital conditions, expanding pediatric healthcare infrastructure, and rising investments in specialized surgical services across countries such as China, India, and Japan. Growing awareness regarding early diagnosis, improving access to pediatric urologists, and increasing adoption of laparoscopic orchiopexy are supporting regional market expansion. In addition, rising healthcare expenditure, expanding newborn screening initiatives, and improving access to advanced diagnostic and treatment facilities are accelerating market growth across the region.
Japan Undescended Testicle Market Insight
The Japan undescended testicle market is witnessing consistent growth due to rising emphasis on neonatal healthcare, early diagnosis of congenital abnormalities, and advancements in pediatric surgical technologies. Hospitals and specialized pediatric urology centers are increasingly adopting advanced diagnostic techniques and minimally invasive procedures for the treatment of undescended testicles. Moreover, increasing awareness of fertility-related complications, established newborn healthcare services, and the country's focus on improving pediatric treatment outcomes are further contributing to market growth.
China Undescended Testicle Market Insight
The China undescended testicle market is growing rapidly, driven by increasing awareness of pediatric urological conditions, expanding healthcare infrastructure, and rising demand for early diagnosis and corrective surgical procedures. Growing adoption of laparoscopic orchiopexy across specialized hospitals and pediatric surgical centers is significantly boosting market demand. In addition, increasing investments in pediatric healthcare, improving access to specialized surgeons, and rising awareness regarding fertility preservation and long-term complications are positioning China as an important growth market for undescended testicle treatment.
U.K. Undescended Testicle Market Insight
The U.K. undescended testicle market is experiencing steady growth, supported by established pediatric healthcare services, increasing awareness of cryptorchidism, and growing emphasis on timely surgical intervention. Increasing availability of specialized pediatric urology services and established clinical guidelines recommending early orchiopexy are contributing to market growth. Furthermore, advancements in laparoscopic procedures, improved diagnostic capabilities, and growing focus on reducing fertility-related complications are strengthening treatment adoption across hospitals and specialized healthcare facilities.
Germany Undescended Testicle Market Insight
The Germany undescended testicle market is expanding steadily due to the country's advanced healthcare infrastructure, strong pediatric surgical capabilities, and increasing adoption of minimally invasive treatment technologies. Hospitals and pediatric urology specialists are increasingly utilizing advanced diagnostic techniques and laparoscopic procedures for managing palpable and non-palpable undescended testicles. Continuous advancements in pediatric surgical equipment, established healthcare reimbursement systems, and strong emphasis on early diagnosis and fertility preservation are further driving market growth in Germany.
Which are the Top Companies in Undescended Testicle Market?
The undescended testicle industry is primarily led by well-established companies, including:
- Coloplast Group (Denmark)
- Rigicon Inc. (U.S.)
- GC Aesthetics (Ireland)
- Osteotec Limited (U.K.)
- UROMED Kurt Drews KG (Germany)
- POLYTECH Health & Aesthetics GmbH (Germany)
- Groupe Sebbin SAS (France)
- Promedon S.A. (Argentina)
- Implantech Associates, Inc. (U.S.)
- Olympus Corporation (Japan)
- Stryker Corporation (U.S.)
- Medtronic (Ireland)
- GE HealthCare (U.S.)
- FUJIFILM Corporation (Japan)
- Richard Wolf GmbH (Germany)
- Cook (U.S.)
- Teleflex Incorporated (U.S.)
- B. Braun SE (Germany)
- KARL STORZ (Germany)
- Boston Scientific Corporation (U.S.)
What are Latest Developments in Undescended Testicle Market?
- In July 2025, Bozhou People's Hospital published a utility-model patent for a testicular traction device designed for use after pediatric cryptorchidism surgery. The device incorporates an adjustable fixing ring and support mechanism intended to maintain the operated testicle in the scrotal position and improve postoperative stabilization. This development reflects innovation in postoperative devices for children undergoing cryptorchidism treatment.
- In October 2024, researchers published an article in Current Urology Reports examining the implementation and use of Intuitive Surgical's da Vinci SP single-port robotic system in pediatric urology. The system uses a single-port cannula with articulated instruments and a high-definition three-dimensional endoscope to support minimally invasive procedures in confined anatomical spaces. The review discussed its potential applications and limitations in pediatric surgery, providing relevant evidence for the development of advanced surgical technologies in pediatric urology.
- In July 2024, Asensus Surgical received U.S. FDA 510(k) clearance for an expanded urological indication of its Senhance Surgical System, covering adult and pediatric patients undergoing urological procedures. The digital laparoscopic platform supports visualization and manipulation of surgical instruments during minimally invasive procedures. This regulatory expansion is relevant to pediatric urology and the broader adoption of advanced laparoscopic technologies.
- In May 2024, Rigicon Inc. announced advancements to its Testi10™ saline-filled testicular prosthesis. The device features an embedded suture loop, medical-grade silicone construction, and multiple size options to support surgical placement and patient-specific selection. The announcement highlighted the company's efforts to improve testicular prosthetic design and patient outcomes. The product is relevant to testicular replacement, rather than corrective orchiopexy.
- In August 2022, the U.S. FDA approved a manufacturing-process supplement for Coloplast's Torosa saline-filled testicular prosthesis. The regulatory update authorized the addition of a new bacterial endotoxin testing method for the device. This development reflects continued quality-control improvements for testicular implants used in reconstructive and replacement procedures.
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.